Regulatory Strategy & Product Classification for Health Products
Determine the correct regulatory status for your product — across EU, FDA, and Health Canada frameworks — before you invest in compliance.
Care Europe helps manufacturers and brand owners determine the precise regulatory classification of their product (medicinal, parapharmaceutical, food supplement, herbal, or cosmetic), define the right compliance pathway, and avoid the costly consequences of misclassification.
One of the most common and expensive mistakes in health product development is misclassifying a product. A product sold as a food supplement in one country may be classified as a medicinal product in another — triggering entirely different regulatory requirements, longer timelines, and higher costs. Care Europe provides expert regulatory positioning to ensure your product follows the right pathway from day one, across EU, FDA, and Health Canada frameworks.
Product Classification: Medicinal vs. Parapharmaceutical vs. Supplement
EU product classification is determined by a product's composition, presentation, and intended function. The same ingredient can place a product in entirely different regulatory categories depending on dosage, health claims, and labelling. Care Europe analyses your product against the relevant EU Directives, national case law, and regulatory precedent to deliver a clear, defensible classification opinion. We cover medicinal products (Directive 2001/83/EC), parapharmaceuticals, food supplements (Directive 2002/46/EC), traditional herbal medicinal products (Directive 2004/24/EC), and cosmetics (Regulation 1223/2009).
Borderline Product Assessment
Many health products fall in the "grey zone" between regulatory categories — for example, a high-dose botanical extract that could be classified as either a food supplement or a traditional herbal medicinal product. Care Europe specialises in borderline product assessment: reviewing the product profile, comparable national precedents, HMPC monographs, and EU Scientific Committee opinions to provide a risk-based classification recommendation. We identify the most commercially viable pathway while managing regulatory risk.
Regulatory Pathway Definition and Strategy
Once a product is classified, Care Europe defines the optimal regulatory pathway: what approvals or notifications are needed, in which order, at what cost, and over what timeline. For products requiring marketing authorisation, we identify the most appropriate procedure (centralised, decentralised, mutual recognition, or national). For food supplements and cosmetics, we map out the notification requirements by target market. The result is a clear, actionable regulatory roadmap with no surprises.
Services & Methods Included
- ✓ Product classification opinion (medicinal/supplement/cosmetic/parapharmaceutical)
- ✓ Borderline product assessment and regulatory positioning
- ✓ THMP (Traditional Herbal Medicinal Product) eligibility review
- ✓ Novel Food status screening for new ingredients
- ✓ Regulatory pathway selection (national, MRP, DCP, centralised)
- ✓ Comparative EU/FDA/Health Canada classification analysis
- ✓ Health claims risk assessment (EU 1924/2006)
- ✓ Regulatory strategy document with timeline and cost estimate
- ✓ Pre-submission scientific advice planning
- ✓ Multi-market classification alignment
Regulatory Standards & Compliance
- EU Directive 2001/83/EC (Medicinal Products)
- EU Directive 2004/24/EC (Traditional Herbal)
- EU Food Supplements Directive 2002/46/EC
- EU Regulation 1223/2009 (Cosmetics)
- EU Novel Food Regulation 2015/2283
- FDA 21 CFR DSHEA / cGMP
- Health Canada NHP Regulations
Industries We Serve
- Pharmaceutical Companies
- Supplement & Nutraceutical Brands
- Herbal & Botanical Product Makers
- Cosmetic & Dermo-Cosmetic Brands
- Parapharmaceutical Manufacturers
- Medical Device Manufacturers (borderline)
Request a Consultation
Tell us about your product and regulatory challenge. We'll respond within 24 hours with an honest assessment and clear next step.
Get a Free Assessment →Frequently Asked Questions
What is a parapharmaceutical product in EU regulation?
A parapharmaceutical is a product sold through pharmacy channels that is not classified as a medicinal product — typically a food supplement, medical device, or cosmetic distributed via pharmacies. The term is not a formal EU legal category but is widely used in practice. Regulatory requirements depend on the product's actual legal classification. Care Europe helps determine which regulatory framework applies and how to position your product appropriately for the pharmacy channel.
What happens if my product is misclassified?
Misclassification can result in product recall, market withdrawal, fines, or criminal liability. A product labelled as a food supplement but meeting the legal definition of a medicinal product may be seized by national authorities. A cosmetic product making medicinal claims may be reclassified and require full marketing authorisation. Care Europe's classification opinions provide a documented, defensible regulatory position based on current EU law and enforcement practice.
How long does a regulatory strategy assessment take?
A regulatory strategy and classification assessment for a single product typically takes 1–2 weeks. For a product portfolio or complex borderline cases, allow 3–4 weeks. Care Europe delivers a written classification opinion with supporting analysis and a recommended regulatory pathway document.
Why brands choose Care Europe for regulatory strategy & product classification
Registered in France
EU regulatory partner with legal standing
Bilingual EN/FR
Reports in English and French
NA–EU Bridge
We understand both regulatory worlds
Ready to start your EU regulatory strategy & product classification?
Tell us about your product and target EU markets. We'll respond within 24 hours with a regulatory assessment and next steps.
Get a Regulatory Quote →